11:11 AM
 | 
Mar 04, 2019
 |  BC Innovations  |  Distillery Therapeutics

New bacteriophage-related therapeutic strategies for colitis and colorectal cancer

DISEASE CATEGORY: Cancer; gastrointestinal

INDICATION: Colorectal cancer; colitis

Patient sample and mouse studies suggest an E. coli bacteriophage cocktail could help treat bacteria-aggravated colorectal cancer and blockade of host-bacteriophage interactions via inhibition of IFNγ or TLR9 could help treat colitis. In ulcerative colitis (UC) patients, gut counts of Caudovirales bacteriophages were higher...

Read the full 226 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >